TheMediTary.Com

Share on Pinterest The FDA has approved islet cellular therapy for type 1 diabetes for the first time. Image credit: Catherine Falls Commercial/Getty Images In 2021, about 8.4 million people globally had type 1 diabetes. There is currently no cure for type 1 diabetes and those with the condition have to provide their body with missing insulin for their entire life. The Food and Drug Administration (FDA) recently approved a new therapy for type 1 diabetes called Lantidra. Studies show after receiving Lantidra, some study participants did not need to administer insulin for more than 5 years. As of 2021, about 8.4 million people around the world live with type 1 diabetes — a chronic disease where the pancreas is not able to produce enough insulin for the body to function correctly. Currently, there is no cure for type 1 diabetes. The main treatment for type 1 diabetes is providing missing insulin through injections or a pump. Additionally, people with type 1 diabetes may be prescribed ad...

Share on Pinterest Gene-editing technology may help scientists create new treatments for Alzheimer’s. Olga Sibirskaya/Stocksy Two innovative CRISPR-based therapeutic approaches for Alzheimer’s disease were unveiled during the Alzheimer’s Association International Conference (AAIC) 2023 in Amsterdam. One method targets the APOE-e4 gene, a significant genetic risk factor for Alzheimer’s, aiming to mitigate its effects. The other method focuses on reducing the production of beta-amyloid, a harmful protein associated with the disease. These developments hold promise for advancing treatment options and provide hope for those affected by Alzheimer’s. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats), a gene editing system, is a method scientists use to edit genes. CRISPR is like a pair of tiny molecular scissors that make a targeted cut in a specific location of a DNA sequence. Once the DNA is cut, scientists can replace faulty genes with a healthy one, remove problematic ge...